C12N 2506/1307
From adult fibroblasts
Official title: from adult fibroblasts
C12N2506/1307 (From adult fibroblasts) appears on 285 US grants and 605 published applications in this corpus.
Search patents in C12N- Granted patents
- 285
- Published applications
- 605
- Assignees
- 304
- Inventors
- 1,038
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 1 |
| 2003 | 0 | 5 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 3 |
| 2009 | 1 | 4 |
| 2010 | 2 | 16 |
| 2011 | 2 | 13 |
| 2012 | 3 | 21 |
| 2013 | 4 | 31 |
| 2014 | 10 | 33 |
| 2015 | 19 | 34 |
| 2016 | 29 | 39 |
| 2017 | 23 | 50 |
| 2018 | 33 | 40 |
| 2019 | 30 | 45 |
| 2020 | 26 | 41 |
| 2021 | 17 | 32 |
| 2022 | 19 | 47 |
| 2023 | 18 | 47 |
| 2024 | 16 | 42 |
| 2025 | 17 | 35 |
| 2026 | 13 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Composition for enhancing reprogramming efficiency from somatic cell to induced pluripotent stem cell, comprising mTOR activator, and method for enhancing reprogramming efficiency by using same6 Oct 2026US 12,753,394 B2Korea University Research and Business Foundation
- Methods for reprogramming cells30 Jun 2026US 12,668,775 B2Monash University
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Methods for reprogramming cells and uses thereof12 May 2026US 12,624,342 B2Genesis Technologies Limited
- Retinal pigment epithelium cell therapy8 Oct 2026US 2026/0306548 A1The Regents of the University of California
- Oct3/4 protein variants, and method for producing induced pluripotent stem cells1 Oct 2026US 2026/0297535 A1Riken
- Synthetic notch receptors for use in customized spatial control of multiple gene expressions and uses thereof1 Oct 2026US 2026/0297539 A1The Regents of the University of California
- Method for producing primed pluripotent stem cells27 Aug 2026US 2026/0250631 A1Kyoto University
- Method for producing three-dimensionally cultered skin model comprising hair follicle structure using fibroblasts and three-dimensionally cultered skin model produced thereby20 Aug 2026US 2026/0242727 A1Tego Science Inc.
Most cited
By later US patents
- Methods for reprogramming somatic cells96US 7,682,828 B2Whitehead Institute for Biomedical Research · 2010
- Compositions for reprogramming somatic cells90US 8,071,369 B2Whitehead Institute for Biomedical Research · 2011
- Chondrocyte-like cells useful for tissue engineering and methods65US 6,489,165 B2The Regents of the University of California · 2002
- Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies63US 7,621,606 B2Advanced Cell Technology, Inc. · 2009
- TGF-beta receptor inhibitors to enhance direct reprogramming55US 8,298,825 B1The General Hospital Corporation · 2012